top of page
Reflections on Psychiatry & Psychology


OCD in the Shadow of Depression
OCD is often diagnosed late (6–10 years) due to varied symptoms and stigma. Depression frequently co-occurs and may obscure OCD. Standard treatment is ERP plus SSRIs; other medications may be added. Emerging evidence suggests ketamine may help treatment-resistant OCD.
Julie Myers, PsyD, MSCP
May 5, 20242 min read


Unlocking the Brain: How the Lateral Habenula Influences Depression and Ketamine Therapy
Introduction: In the intricate landscape of neuroscience, the lateral habenula (LHb) stands out as a critical structure in understanding depression. This blog explores the LHb's role, its connection to depressive symptoms, and how ketamine therapy offers new hope. The Lateral Habenula: A Critical Brain Structure The lateral habenula (LHb) is a small, symmetrical, paired nucleus located deep within the brain, nestled between the two thalamic bodies. It is intricately connecte
Alexander Papp, MD
Apr 28, 20242 min read


Ketamine and the Future of Mental Health: Insights from the 2024 Oxford International Conference
The 2024 Oxford Ketamine Conference gathered global experts to discuss ketamine’s science and clinical use in mental health. Key themes included its rapid antidepressant effects, mechanisms of action, and improving treatment approaches, highlighting interdisciplinary collaboration and future research.
A. Papp MD & Julie Myers, PsyD, MSCP
Mar 31, 20242 min read


Part 5 - Relationship of Stress to the Expression and Treatment of Bipolar Disorder
Psychosocial treatment for bipolar disorder includes psychoeducation, CBT, social rhythm therapy, family therapy, and group work. These target stress, routines, cognition, and relationships to reduce relapse. Early intervention and stress prevention—especially after childhood adversity—may improve course and outcomes.
Julie Myers, PsyD, MSCP
Mar 24, 20243 min read


Part 4 - Relationship of Stress to the Expression and Treatment of Bipolar Disorder
Treatment The treatment of BD is complex. Psychosocial treatments are necessary but rarely sufficient for controlling relapse or acute symptoms. From my observations, the treatment of BD is as much of an art as it is a science, with different researchers and clinicians having different ideas as to what is the appropriate formulation. Critically important is the assessment of suicide throughout the treatment. Suicidal ideation and suicide completion is a very real possib
info926315
Mar 17, 20242 min read


Part 3 - Relationship of Stress to the Expression and Treatment of Bipolar Disorder
Stress is closely linked to bipolar disorder (BD), though its role in causation is unclear. BD is highly heritable. The Kindling theory suggests early stress triggers first episodes, after which episodes may become autonomous or stress-sensitized. Early trauma predicts earlier onset, greater severity, and poorer outcomes.
Julie Myers, PsyD, MSCP
Mar 10, 20244 min read


Part 2 - Relationship of Stress to the Expression and Treatment of Bipolar Disorder
The Comorbidity of Bipolar Disorder and Stress disorders Comorbidity is common in BD, further complicating the diagnosis. In one study, a comorbid disorder was found in all of the samples, and in 59% the condition preceded the onset of BD symptoms (Kessler, Rubinow, Holmes, Abelson, & Ahao, 1997). Common among the comorbid disorders are anxiety, substance abuse, ADHD, Oppositional-Defiant Disorder, Bulimia, Social Phobia, Panic Disorder, and Obsessive Compulsive Disorder
Julie Myers, PsyD, MSCP
Mar 3, 20243 min read


Part 1 - Relationship of Stress to the Expression and Treatment of Bipolar Disorder
It is generally agreed in the literature that stress affects the course and severity of Bipolar Disorder. Diagnosis is particularly difficult, because those with BD often do not recognize their episodes and so do not report their presence.
Julie Myers, PsyD, MSCP
Feb 25, 20243 min read


The Risks of At-Home Ketamine: A Cautionary Perspective
Introduction Ketamine, an NMDA receptor antagonist, has shown promise in the treatment of various psychiatric disorders, including depression and PTSD. Its rapid-acting therapeutic effects have made it an appealing option in clinical settings under strict supervision. However, the trend towards take-home ketamine, facilitated through prescriptions for nasal sprays and oral lozenges, raises significant safety and efficacy concerns. This blog entry explores some of the reasons
Julie Myers, PsyD, MSCP
Jan 28, 20243 min read


Exploring Ketamine Therapy Risks in Light of Matthew Perry's Untimely Passing
Matthew Perry, celebrated for his iconic role on "Friends," tragically passed away on October 28, 2023, after being found unresponsive at the heated end of his swimming pool. His live-in personal assistant discovered him upon returning from errands. Despite immediate efforts to revive him, Perry was pronounced dead by emergency personnel at 4:17 p.m. Mr. Perry battled several health issues including chronic obstructive pulmonary disease (COPD), diabetes, and had a history of
Alexander Papp, MD
Dec 31, 20232 min read


A New Oral Medication for Postpartum Depression
Zurzuvae, the first FDA-approved oral pill for postpartum depression, is taken for 14 days and can reduce symptoms within days. Costing about $15,900, access may be limited despite its rapid action compared with traditional antidepressants.
Alexander Papp, MD
Nov 26, 20232 min read


Call 988!
The “988 Lifeline” service was launched in July 2022, progressing from the narrow focus on suicide prevention as the “National Suicide Prevention Lifeline” to a wider attention of forms of acute distress (and also requiring a much simpler dial code). A recent study on 988 Lifeline reveals that while it has received millions of calls, texts, and online messages, it might not be living up to its full potential. The researchers found that people dealing with severe psychologic
Alexander Papp, MD
Oct 29, 20232 min read


Understanding Methylfolate: Genetic Connection and Clinical Insights
Methylfolate, the active form of folate (B9), supports serotonin and dopamine production and may help depression, especially in people with MTHFR variants or treatment-resistant cases. It can cause GI upset or insomnia and should be used cautiously, especially with SSRIs, under medical supervision.
Alexander Papp, MD
Sep 24, 20232 min read


Cannabis DUI
In areas where cannabis is legal, more young people are driving under its influence than alcohol. Misconceptions about impairment, lack of clear THC limits, and normalization of use raise road safety concerns, highlighting the need to balance legalization with prevention.
Alexander Papp, MD
Aug 27, 20232 min read


Another Independent Pharmacy Closes
After 30+ years serving San Diego, Point Loma Shelter Island Drug and Point Loma Cabrillo Drug closed. Crime and PBM “clawbacks” strained the small, personal pharmacies. Owner Michael Saad sold to a chain after years of 12-hour days. Loyal patrons will miss the care.
Alexander Papp, MD
Jul 30, 20232 min read


Don't Throw Out the Serotonin Theory Just Yet!
The serotonin theory of depression has been around for a good 60 years and is often used as justification for the use of antidepressants, specifically selective serotonin re-uptake inhibitors (SSRIs). Understandably, a review published recently by psychiatric researcher Joanna Moncrieff, which concluded that there was no consistent evidence of an association between serotonin and depression, and no support for the hypothesis that depression is caused by lowered serotonin act
Alexander Papp, MD
Jun 25, 20232 min read


A New PAM on the Block
Zuranolone (Zurzuvae) is the first oral GABA-modulating antidepressant for postpartum depression. Taken for 14 days, it can improve symptoms within 3 days; benefits may last weeks. Common side effects include drowsiness and dizziness.
Alexander Papp, MD
May 28, 20232 min read


The "Pipeline"
There are several exciting developments in the field of antidepressants, with various drugs currently in the pipeline. still in various stages of development. Clinical trials are ongoing to evaluate their safety, effectiveness, and potential side effects.
Alexander Papp, MD
Apr 3, 20232 min read


More on Brain Zaps
A 2022 study confirmed brain zaps as real antidepressant-withdrawal symptoms. Restarting or slowly tapering meds may help. Most improve over time, but some suffer for years. Despite this, psychiatry has shown little response.
Alexander Papp, MD
Mar 26, 20234 min read


Supplements with Antianxiety Effects
Nutraceuticals—herbs and vitamins like ashwagandha, kava, chamomile, and CBD—may ease mild anxiety but aren’t a substitute for professional treatment. Consult a healthcare provider.
Alexander Papp, MD
Feb 26, 20232 min read
bottom of page